NCT03189446 · FLOW
Participant flow
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- groups
- description
- Vaginal cuff brachytherapy followed by Carboplatin (AUC 6) on day 1and Paclitaxel 80 mg/m2 IV over 1 hour days 1, 8, and 15 X 3 total cycles Vaginal Cuff Brachytherapy: Within 12 weeks of surgery. Either LDR or HDR brachytherapy will be permitted Carboplatin: Carboplatin IV on day 1 of a 21 day cycle for 3 cycles Paclitaxel: Paclitaxel IV on days 1,8 and 15 of a 21 day cycle for 3 cycles
- id
- FG000
- title
- Vaginal Cuff Brachytherapy + Chemotherapy
- periods
- drop Withdraws
- reasons
- group Id
- FG000
- num Subjects
- 2
- type
- Adverse Event
- reasons
- group Id
- FG000
- num Subjects
- 2
- type
- Withdrawal by Subject
- reasons
- group Id
- FG000
- num Subjects
- 1
- type
- Physician Decision
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 32
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 27
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 5
- type
- NOT COMPLETED
- title
- Overall Study
- pre Assignment Details
- Of 39 enrolled participants, 32 met inclusion criteria and evaluable then assign to the single arm treatment.
- recruitment Details
- Participants were recruited at a single institution from October 2017 to July 2019. The first patient was enrolled on October 2, 2017 and the last patient was enrolled on July 23, 2019
Complete source fields
- groups
- description
- Vaginal cuff brachytherapy followed by Carboplatin (AUC 6) on day 1and Paclitaxel 80 mg/m2 IV over 1 hour days 1, 8, and 15 X 3 total cycles Vaginal Cuff Brachytherapy: Within 12 weeks of surgery. Either LDR or HDR brachytherapy will be permitted Carboplatin: Carboplatin IV on day 1 of a 21 day cycle for 3 cycles Paclitaxel: Paclitaxel IV on days 1,8 and 15 of a 21 day cycle for 3 cycles
- id
- FG000
- title
- Vaginal Cuff Brachytherapy + Chemotherapy
- periods
- drop Withdraws
- reasons
- group Id
- FG000
- num Subjects
- 2
- type
- Adverse Event
- reasons
- group Id
- FG000
- num Subjects
- 2
- type
- Withdrawal by Subject
- reasons
- group Id
- FG000
- num Subjects
- 1
- type
- Physician Decision
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 32
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 27
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 5
- type
- NOT COMPLETED
- title
- Overall Study
- pre Assignment Details
- Of 39 enrolled participants, 32 met inclusion criteria and evaluable then assign to the single arm treatment.
- recruitment Details
- Participants were recruited at a single institution from October 2017 to July 2019. The first patient was enrolled on October 2, 2017 and the last patient was enrolled on July 23, 2019
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle